Jeremy Gowler
Directeur/Membre du Conseil chez Versatope Therapeutics, Inc.
Fortune : - $ au 30/06/2024
Profil
Jeremy Gowler's current job(s) include being a Director at Versatope Therapeutics, Inc. and a Director at Vaccine & Infectious Disease Organization.
His former job(s) include being a Senior Director-Marketing at Novartis Vaccines & Diagnostics, Inc., a Director-Medical Affairs at Novartis Vaccines & Diagnostics Services AG, and a Vice President-Global Commercial at Emergent Travel Health, Inc. He also worked as a Brand Manager-Marketing at Novartis Pharmaceuticals Canada, Inc. and as the Head-Biopharmaceuticals at Sandoz Biopharmaceuticals.
Additionally, Mr. Gowler has an upcoming job as the Chief Executive, Operating & Commercial Officer at Invivyd, Inc. He completed his undergraduate degree at the University of Victoria.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18/12/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Jeremy Gowler
| Sociétés | Poste | Début |
|---|---|---|
Versatope Therapeutics, Inc.
 Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Directeur/Membre du Conseil | 01/01/2021 |
| Vaccine & Infectious Disease Organization | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeremy Gowler
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVYD, INC. | Directeur Général | 30/05/2024 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2018 |
| Sandoz Biopharmaceuticals | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Sales & Marketing | - |
| Novartis Vaccines & Diagnostics Services AG | Directeur Technique/Scientifique/R&D | - |
Formation de Jeremy Gowler
| University of Victoria | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
| Novartis Vaccines & Diagnostics Services AG | |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Health Technology |
| Vaccine & Infectious Disease Organization | |
| Sandoz Biopharmaceuticals |
